Sandrine Major1, Kevin Vézina2, Sze Man Tse2. 1. Faculty of Medicine, McGill University, Montreal, Canada. 2. Division of Respiratory Medicine, Department of Pediatrics, Sainte-Justine University Hospital Center, University of Montreal, Montreal, Canada.
Abstract
Background: To determine the lung function of children admitted to the intensive care unit (ICU) for a severe asthma exacerbation in the medium- to long-term following hospital discharge. Methods: We performed a retrospective chart review of children ≥6 years of age admitted to the ICU for a severe asthma exacerbation at a tertiary care center from January 1, 2000, to December 31, 2013. Lung function was ascertained during outpatient follow-up visits at 3-12 months and 12-24 months postdischarge. A total of 72 subjects met the inclusion criteria. Results: Subjects were predominantly boys (56.9%) and had a mean (standard deviation [SD]) age at admission of 10.3 years (3.4 years). The median (interquartile range) length of stay in the ICU was 1 day (1-3 days). Thirty-eight and 28 subjects performed pulmonary function tests with acceptable technique at the 3-12 months and 12-24 months postdischarge visits, respectively. At 3-12 months, the mean (SD) predicted forced expiratory volume in 1 s (FEV1) and forced expiratory flow between 25% and 75% of vital capacity (FEF25-75) percent were 95.9 (16.7) and 76.7 (25.8), respectively, and 97.4 (17.6) and 70.5 (24.9), respectively, at 12-24 months. FEV1/forced vital capacity (FEV1/FVC) was 81.7 (8.3) at 3-12 months and 79.3 (7.7) at 12-24 months. A paired t-test on 20 subjects who performed acceptable spirometry at both visits showed a significant intraindividual decrease in FEV1 (P = 0.008), FEF25-75 (P = 0.02), and FEV1/FVC (P = 0.01) between the 2 time points. Conclusion: Although prospective studies are required to confirm our findings, our study suggests that children admitted to the ICU for severe asthma exacerbations may be at risk for declining pulmonary function in the medium- to long-term postdischarge.
Background: To determine the lung function of children admitted to the intensive care unit (ICU) for a severe asthma exacerbation in the medium- to long-term following hospital discharge. Methods: We performed a retrospective chart review of children ≥6 years of age admitted to the ICU for a severe asthma exacerbation at a tertiary care center from January 1, 2000, to December 31, 2013. Lung function was ascertained during outpatient follow-up visits at 3-12 months and 12-24 months postdischarge. A total of 72 subjects met the inclusion criteria. Results: Subjects were predominantly boys (56.9%) and had a mean (standard deviation [SD]) age at admission of 10.3 years (3.4 years). The median (interquartile range) length of stay in the ICU was 1 day (1-3 days). Thirty-eight and 28 subjects performed pulmonary function tests with acceptable technique at the 3-12 months and 12-24 months postdischarge visits, respectively. At 3-12 months, the mean (SD) predicted forced expiratory volume in 1 s (FEV1) and forced expiratory flow between 25% and 75% of vital capacity (FEF25-75) percent were 95.9 (16.7) and 76.7 (25.8), respectively, and 97.4 (17.6) and 70.5 (24.9), respectively, at 12-24 months. FEV1/forced vital capacity (FEV1/FVC) was 81.7 (8.3) at 3-12 months and 79.3 (7.7) at 12-24 months. A paired t-test on 20 subjects who performed acceptable spirometry at both visits showed a significant intraindividual decrease in FEV1 (P = 0.008), FEF25-75 (P = 0.02), and FEV1/FVC (P = 0.01) between the 2 time points. Conclusion: Although prospective studies are required to confirm our findings, our study suggests that children admitted to the ICU for severe asthma exacerbations may be at risk for declining pulmonary function in the medium- to long-term postdischarge.
Entities:
Keywords:
critical care; pulmonary function testing; respiratory care; severe asthma
Authors: Shuang Huang; Monica M Vasquez; Marilyn Halonen; Fernando D Martinez; Stefano Guerra Journal: Eur Respir J Date: 2014-10-16 Impact factor: 16.671
Authors: Jason S Debley; Elizabeth S Cochrane; Gregory J Redding; Edward R Carter Journal: Ann Allergy Asthma Immunol Date: 2012-06-26 Impact factor: 6.347
Authors: Chén C Kenyon; Patrice R Melvin; Vincent W Chiang; Marc N Elliott; Mark A Schuster; Jay G Berry Journal: J Pediatr Date: 2013-11-14 Impact factor: 4.406
Authors: Mousheng Xu; Kelan G Tantisira; Ann Wu; Augusto A Litonjua; Jen-hwa Chu; Blanca E Himes; Amy Damask; Scott T Weiss Journal: BMC Med Genet Date: 2011-06-30 Impact factor: 2.103
Authors: Craig M Riley; Sally E Wenzel; Mario Castro; Serpil C Erzurum; Kian Fan Chung; Anne M Fitzpatrick; Benjamin Gaston; Elliot Israel; Wendy C Moore; Eugene R Bleecker; William J Calhoun; Nizar N Jarjour; William W Busse; Stephen P Peters; W Gerald Teague; Ronald Sorkness; Fernando Holguin Journal: PLoS One Date: 2015-12-30 Impact factor: 3.240